{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T16:27:23Z","timestamp":1763224043502,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Epidemiology"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.annepidem.2010.09.002","type":"journal-article","created":{"date-parts":[[2011,2,5]],"date-time":"2011-02-05T04:33:30Z","timestamp":1296880410000},"page":"149-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Are Statin Medications Associated with Lower Urinary Tract Symptoms in Men and Women? Results from the Boston Area Community Health (BACH) Survey"],"prefix":"10.1016","volume":"21","author":[{"given":"Susan A.","family":"Hall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gretchen R.","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol L.","family":"Link","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William D.","family":"Steers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varant","family":"Kupelian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John B.","family":"McKinlay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annepidem.2010.09.002_bib1","unstructured":"IMS Health Incorporated. Top Therapeutic Classes by U.S. Sales. Available at: http:\/\/www.imshealth.com\/deployedfiles\/imshealth\/Global\/Content\/StaticFile\/Top_Line_Data\/Top%20Therapy%20Classes%20by%20U.S.Sales.pdf. Accessed November 9, 2010."},{"key":"10.1016\/j.annepidem.2010.09.002_bib2","series-title":"AHFS Drug Information 2006","first-page":"1674","article-title":"HMG-CoA reductase inhibitors","author":"American Society of Health-System Pharmacists","year":"2006"},{"key":"10.1016\/j.annepidem.2010.09.002_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2369-9-4","article-title":"The Lipid lowering and Onset of Renal Disease (LORD) Trial: a randomized double blind placebo controlled trial assessing the effect of atorvastatin on the progression of kidney disease","volume":"9","author":"Fassett","year":"2008","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.annepidem.2010.09.002_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11918-008-0011-5","article-title":"Inflammatory mechanisms associated with prostatic inflammation and lower urinary tract symptoms","volume":"6","author":"St. Sauver","year":"2008","journal-title":"Curr Prostate Rep"},{"key":"10.1016\/j.annepidem.2010.09.002_bib5","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1097\/01.ju.0000085024.47406.6c","article-title":"Y-27632, a Rho-kinase inhibitor, inhibits proliferation and adrenergic contraction of prostatic smooth muscle cells","volume":"170","author":"Rees","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.annepidem.2010.09.002_bib6","doi-asserted-by":"crossref","first-page":"L1323","DOI":"10.1152\/ajplung.00447.2003","article-title":"Connective tissue growth factor expression and induction by transforming growth factor-beta is abrogated by simvastatin via a Rho signaling mechanism","volume":"287","author":"Watts","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.annepidem.2010.09.002_bib7","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1345\/aph.10124","article-title":"Beneficial effects of statins in coronary artery disease\u2014beyond lowering cholesterol","volume":"34","author":"Sotiriou","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.annepidem.2010.09.002_bib8","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.juro.2008.04.002","article-title":"The relationship of common medical conditions and medication use with symptoms of painful bladder syndrome: results from the Boston Area Community Health Survey","volume":"180","author":"Hall","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.annepidem.2010.09.002_bib9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.eururo.2007.02.032","article-title":"Atorvastatin treatment for men with lower urinary tract symptoms and benign prostatic enlargement","volume":"52","author":"Mills","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.annepidem.2010.09.002_bib10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.eururo.2007.03.013","article-title":"Measuring the urologic iceberg: design and implementation of the Boston Area Community Health (BACH) Survey","volume":"52","author":"McKinlay","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.annepidem.2010.09.002_bib11","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0022-5347(17)36966-5","article-title":"The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association","volume":"148","author":"Barry","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.annepidem.2010.09.002_bib12","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/aje\/kwg051","article-title":"Risk factors for lower urinary tract symptoms in a population-based sample of African-American men","volume":"157","author":"Joseph","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.annepidem.2010.09.002_bib13","first-page":"168","article-title":"The Slone Drug Dictionary: a research driven pharmacoepidemiology tool","volume":"12","author":"Kelley","year":"2003","journal-title":"Pharmacoepidemiol Drug Safety"},{"year":"2007","series-title":"AHFS Drug Information","author":"American Society of Health-System Pharmacists","key":"10.1016\/j.annepidem.2010.09.002_bib14"},{"key":"10.1016\/j.annepidem.2010.09.002_bib15","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2307\/4593972","article-title":"Manual for scoring socioeconomic status for research on health behavior","volume":"85","author":"Green","year":"1970","journal-title":"Public Health Rep"},{"key":"10.1016\/j.annepidem.2010.09.002_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1017\/S1041610299005694","article-title":"A revised CES-D measure of depressive symptoms and a DSM-based measure of major depressive episodes in the elderly","volume":"11","author":"Turvey","year":"1999","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.annepidem.2010.09.002_bib17","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.annepidem.2010.09.002_bib18","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/bmj.315.7116.1151","article-title":"Confounding and indication for treatment in\u00a0evaluation of drug treatment for hypertension","volume":"315","author":"Grobbee","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.annepidem.2010.09.002_bib19","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1001\/archinte.166.21.2381","article-title":"Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey","volume":"166","author":"Kupelian","year":"2006","journal-title":"Arch Intern Med"},{"year":"1997","series-title":"Analysis of Incomplete Multivariate Data","author":"Schafer","key":"10.1016\/j.annepidem.2010.09.002_bib20"},{"year":"1998","series-title":"Modern Epidemiology","author":"Rothman","key":"10.1016\/j.annepidem.2010.09.002_bib21"},{"key":"10.1016\/j.annepidem.2010.09.002_bib22","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.urology.2007.06.1117","article-title":"Relationship of lifestyle and clinical factors to lower urinary tract symptoms: results from Boston Area Community Health survey","volume":"70","author":"Litman","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.annepidem.2010.09.002_bib23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1464-410X.2007.07332.x","article-title":"Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community-dwelling men","volume":"101","author":"Parsons","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.annepidem.2010.09.002_bib24","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/sj.ijir.3901578","article-title":"Lower urinary tract symptoms and erectile dysfunction; links for diagnosis, management and treatment","volume":"19","author":"Ponholzer","year":"2007","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.annepidem.2010.09.002_bib25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000028323","article-title":"Effects of in vivo ischemia on contractile responses of rabbit bladder field stimulation, carbachol, ATP and KCl","volume":"59","author":"Bratslavsky","year":"1999","journal-title":"Pharmacology"},{"key":"10.1016\/j.annepidem.2010.09.002_bib26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00005392-200101000-00072","article-title":"The effect of bladder outflow obstruction on detrusor blood flow changes during the voiding cycle in conscious pigs","volume":"165","author":"Greenland","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.annepidem.2010.09.002_bib27","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/S0022-5347(05)68236-5","article-title":"Overactivity and structural changes in the chronically ischemic bladder","volume":"162","author":"Azadzoi","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.annepidem.2010.09.002_bib28","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/nau.10076","article-title":"Focal hypoxia of the obstructed rabbit bladder wall correlates with intermediate decompensation","volume":"22","author":"Levin","year":"2003","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.annepidem.2010.09.002_bib29","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1590\/S1677-55382008000500003","article-title":"The effects of lovastatin on conventional medical treatment of lower urinary tract symptoms with finasteride","volume":"34","author":"Stamatiou","year":"2008","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.annepidem.2010.09.002_bib30","article-title":"Statin use and decreased risk of benign prostatic enlargement and lower urinary tract symptoms","author":"St. Sauver","year":"2010","journal-title":"BJU Int"}],"container-title":["Annals of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279710003613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279710003613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T02:09:20Z","timestamp":1760926160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047279710003613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S1047279710003613"],"URL":"https:\/\/doi.org\/10.1016\/j.annepidem.2010.09.002","relation":{},"ISSN":["1047-2797"],"issn-type":[{"type":"print","value":"1047-2797"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Are Statin Medications Associated with Lower Urinary Tract Symptoms in Men and Women? Results from the Boston Area Community Health (BACH) Survey","name":"articletitle","label":"Article Title"},{"value":"Annals of Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annepidem.2010.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}